# Federal obligations for COVID-19 related R&D and all other R&D, by agency: FY 2020

**Modal ID:** 6466

**Table Number:** 132

**Type:** RH (Row Hierarchical)

**Units:** (Dollars in millions)

## Notes

Because of rounding, detail may not add to total. Only those agencies and subdivisions that had obligations or outlays in variables represented by this table appear in the table. Agencies were requested to report their FY 2020 obligations for COVID-19 related R&D that were from their agency's initial appropriations as well as from any stimulus funds received from the Coronavirus Aid, Relief, and Economic Security Act plus any other pandemic-related supplemental appropriations. The Biomedical Advanced Research and Development Authority accounted for 66% of all COVID-19 research; a substantial portion of these funds include transfers to other agencies for COVID-19 R&D in support of Operation Warp Speed. See technical table A-2 for additional notes associated with the agencies listed in this table.

## Sources

National Center for Science and Engineering Statistics, Survey of Federal Funds for Research and Development, FYs 2020â€“21.

## Files

- `data.csv`: The table data in CSV format
- `croissant_metadata.json`: ML Croissant metadata for machine learning applications

## Structure

- Row hierarchy depth: 5
- Column hierarchy depth: 1
- Time series: No

## Special Values

- `i`: imputed value
- `r`: revised value
- `D`: suppressed to avoid disclosure of confidential information
- `*`: value between 0.00% and 0.05%
